GLMD Galmed Pharmaceuticals Ltd.

NASDAQ
$0.52

Galmed Pharmaceuticals Ltd. (GLMD) is expected to report earnings on October 7, 2026, before the market open.

Galmed Pharmaceuticals Reported Earnings
Wednesday, July 8, 2026 · 12:00 AM ET
Earnings Date
Oct 7
Wednesday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Sector

Healthcare